title: [The use of the alpha 1-adrenoblocker doxazosin in the pharmacotherapy of disorders of urine outflow of spastic origin].
abstract: Our objective in this study was summing up of results of clinical studies on effectiveness of a selective alpha-adrenoblocker doxazosine in the pharmacotherapy of reflex and spastic disorders of outflow of urine. Doxazosine ("Cardura", Pfizer Inc.) was prescribed per os once per day in the morning after meal in a dose of 2-4 mg. The drug can be used not only as a hypotensive agent but also in conservative treatment of patients with prostate hyperplasia. It was found to be very effective in attempts to bring the disordered outflow of urine back to normal in patients presenting with calculi in the lower third of ureters as well as those with prior prostata resection; in affections of and injuries to the brain and spinal cord.
authors: M I
authors: MI
authors: Ukhal'
authors: O I
authors: OI
authors: Malomuzh
authors: V V
authors: VV
authors: Strashnyĭ
authors: M V
authors: MV
authors: Shumilin
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D003692:Delayed-Action Preparations; D017292:Doxazosin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011468:Prostatectomy; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy; D013035:Spasm / Q000150:complications / Q000188:drug therapy; D014514:Ureteral Calculi / Q000150:complications / Q000188:drug therapy; D001750:Urinary Bladder, Neurogenic / Q000150:complications / Q000188:drug therapy; D014555:Urination Disorders / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000319:Adrenergic beta-Antagonists; D003692:Delayed-Action Preparations; D017292:Doxazosin